- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Canada sinks $660 million into medical equipment
The government of Canada announced it will spend US$660 million over the next five years for new medical equipment, the bulk of which will be capital equipment items such as CT and MRI scanners. Half of the funds will be made available immediately.These
The government of Canada announced it will spend US$660 million over the next five years for new medical equipment, the bulk of which will be capital equipment items such as CT and MRI scanners. Half of the funds will be made available immediately.
These investments are part of an overall $15.7 billion five-year budget to support the so-called health renewal agreements between the federal and provincial governments.
Canada's medical devices industry association, MEDEC, welcomed the commitment. In a report, the Canadian Medical Association blasted the government health program.
"Canada ranks poorly when it comes to the availability of technology," the report said.
It also pointed out that Canada ranks 11th and 12th in the world, respectively, for MRI and CT scanners.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can AI Enhance PET/MRI Assessment for Extraprostatic Tumor Extension in Patients with PCa?
December 17th 2024The use of an adjunctive machine learning model led to 17 and 21 percent improvements in the AUC and sensitivity rate, respectively, for PET/MRI in diagnosing extraprostatic tumor extension in patients with primary prostate cancer.
